KEKhawaja F. Mbbs Ejaz

Khawaja F. Mbbs Ejaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Khawaja F. Mbbs Ejaz has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Use of telemedicine to tackle health problems in South Asia during the COVID-19 era and beyond: a systematic review

    by Muhammad K. Mbbs Saleem, Komal Mbbs Sattar, Khawaja F. Mbbs Ejaz, Muneeb U. Mbbs Rehman, Humayun Mbbs Saleem, Soffia Mbbs Khursheed, Amna Mbbs Akbar, Jahanzeb Mbbs Ahmed, Maham Mbbs Tariq, Sarosh K. Mbbs Jadoon, et al.

    Introduction: Telemedicine (TM) and teleconsultation services flourished during coronavirus disease 2019 (COVID-19) transmission to avoid COVID-19 infection and physical contact. Many physicians switched to the virtual treatment mode and nearly all types of health disciplines were covered. Through this systematic review, the authors tried to explore the strengths and weaknesses of TM, identify the barriers to adopting TM by population, and explain the limitations of this healthcare delivery model. Methods and results: In this systematic review, 28 studies were included (>53% high-quality studies) as eligible, where nearly 75% (n=21) of the studies were from India, and the remaining 25% (n=7) were from Pakistan, Bangladesh, Sri Lanka, and Nepal. Advice related to cancer, autoimmune diseases, and neurological diseases were the most common among the health disciplines in which TM was used. A peak in teleconsultation was observed during the high transmission phase of COVID-19, although major queries were associated with existing health complications and comorbidities. Conclusion: Other than a few concerns regarding connectivity, privacy, and diagnosis, TM was in fact affordable, timesaving, feasible, and accurate, which ensured a highly satisfying experience among the participants (>80%).


  • Open Access

    INVESTIGATING THE ASSOCIATION BETWEEN BLOOD GROUPS, D-DIMER, AND NEUTROPHIL TO LYMPHOCYTE RATIO IN RELATION TO DISEASE SEVERITY AND OUTCOME: RETROSPECTIVE COHORT STUDY ON COVID-19 PATIENTS

    by Sohail Khan Raja, Mohammad Ali Arshad Abbasi, Rubina Rafique Shiekh, Tashbih E Batool, Khawaja Faizan Ejaz, Muhammad Ishraf Ul Islam, Amna Akbar, Maham Tariq, Sabahat Tasneem, Sarosh Khan Jadoon

    Introduction: chronic obstructive pulmonary disease, asthma and tuberculosis are well known fatal disorders. Corona-virus disease of 2019 (COVID-19) caused worldwide pandemic and it affected lungs and caused deaths more than other causes combined in one year. Research has been focused on different aspects of COVID-19 since it emerged. Blood groups and inflammatory markers are being investigated. The thromboembolism marker D-dimer and other coagulation markers are intensively being studied. Methodology: We conducted a retrospective cohort study in Azad Jammu Kashmir, Pakistan to explore the relationship between blood groups and neutrophil to lymphocyte ratio (NLR) and D-dimers in relation to disease severity and outcomes. Results: The blood groups A and B+ve are more affected than other blood groups (58%) and NLR and D-dimer predict disease severity (p<-0.05). D-dimer is associated with blood groups, but NLR is not. Conclusion: The present study gave good insight into role of blood groups, NLR and D-Dimer values in COVID-19 disease severity and outcomes. We recommend that further studies should be done, and more inflammatory markers must be explored as the present study represents only one area of our country.